Interesting BHC Call Options For August 8th

An analysis details a covered call strategy on Bausch Health Companies (BHC), proposing buying shares at $6.48 and selling an August 8th $7.00 strike call for $0.30. This strategy yields a 12.65% return if the stock is called away, or a 4.63% premium gain (39.30% annualized) if the out-of-the-money contract expires worthless, an outcome with a 57% probability. While capping upside beyond $7.00, the trade benefits from an implied volatility of 73%, exceeding BHC's 59% trailing 12-month actual volatility.

Analysis

The article outlines a covered call strategy on Bausch Health Companies (BHC), involving the purchase of shares at $6.48 and the simultaneous sale of an August 8th expiration call option at a $7.00 strike price for a $0.30 premium. This structure presents two distinct outcomes: a maximum total return of 12.65% if BHC's stock price exceeds $7.00 and the shares are called away, or a 4.63% return on capital (annualized to 39.30%) if the option expires worthless, an event with a stated probability of 57%. A key factor underpinning this trade is the significant spread between the option's implied volatility of 73% and the stock's trailing twelve-month actual volatility of 59%. This suggests the option premium is rich relative to the stock's recent price behavior, creating a potentially advantageous setup for an option seller. However, the strategy inherently caps upside potential, a critical consideration given the article's reminder to evaluate the company's fundamentals and trading history.

Key Decisions for Investors

• Investors seeking to generate income on BHC shares can consider this covered call strategy to capture the 4.63% premium, which offers an attractive annualized yield of 39.30% if the option expires worthless.
• The significant premium of implied volatility (73%) over historical volatility (59%) suggests an opportune moment for selling options on BHC, as the market is pricing in more future price movement than has recently occurred.
• Bullish investors who anticipate a sharp rally in BHC shares above the $7.00 strike price before the August expiration should avoid this strategy, as it would cap their upside and force the sale of their shares at a predetermined price.